C4 Therapeutics, Inc.

CCCC

$3.74

-1.32%

N/A-$0.05

Healthcare

Biotechnology

NASDAQ

Negociación activa

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutic candidates. Its core strategy involves degrading proteins ...

Transacciones de insiders de CCCC

Compras (A)

Since Jun 24, 2026

Ventas (D)

Since Jun 24, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Jul 10, 2026	REYNO LEONARD	officer: Chief Medical Officer	Common Stock	A	15,325	—
Jul 10, 2026	REYNO LEONARD	officer: Chief Medical Officer	Common Stock	D	7,397	$4.06
Jul 1, 2026	Anderson Kenneth Carl	director	Common Stock	A	2,650	$4.34
Jul 1, 2026	GROGAN DONNA ROY	director	Common Stock	A	3,341	$4.34
Jun 24, 2026	Hughes Owen	director	Stock Option (Right to Buy)	A	62,000	$4.25

Resumen de trading de insiders

Compras (A)

Ventas (D)

Acciones compradas totales

393,316

Acciones vendidas totales

7,397

Actividad mensual de insiders

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Por cargo - Acciones

Eje X: acciones, ordenado por acciones totales desc.

Por cargo - Conteos

Eje X: conteos, ordenado por conteos A+D desc.

Personas clave: actividad de compra/venta y precio

REYNO LEONARD

officer: Chief Medical Officer • 2 transacciones

Anderson Kenneth Carl

director • 2 transacciones

GROGAN DONNA ROY

director • 1 transacciones

Hughes Owen

director • 1 transacciones

Tabla de transacciones

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio	Valor
Jul 10, 2026	REYNO LEONARD	officer: Chief Medical Officer	Common Stock	A	15,325	—	—
Jul 10, 2026	REYNO LEONARD	officer: Chief Medical Officer	Common Stock	D	7,397	$4.06	$30,031.82
Jul 1, 2026	Anderson Kenneth Carl	director	Common Stock	A	2,650	$4.34	$11,501.00
Jul 1, 2026	GROGAN DONNA ROY	director	Common Stock	A	3,341	$4.34	$14,499.94
Jun 24, 2026	Hughes Owen	director	Stock Option (Right to Buy)	A	62,000	$4.25	$263,500.00
Jun 24, 2026	Hoerter Steven L.	director	Stock Option (Right to Buy)	A	62,000	$4.25	$263,500.00
Jun 24, 2026	Koppikar Utpal	director	Stock Option (Right to Buy)	A	62,000	$4.25	$263,500.00
Jun 24, 2026	Anderson Kenneth Carl	director	Stock Option (Right to Buy)	A	62,000	$4.25	$263,500.00
Jun 24, 2026	Cooper Ronald Harold Wilfred	director	Stock Option (Right to Buy)	A	62,000	$4.25	$263,500.00
Jun 24, 2026	Bessen Laura	director	Stock Option (Right to Buy)	A	62,000	$4.25	$263,500.00

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal